Detail
| LncRNA Name | SNHG5 |
| Synonyms | SNHG5, C6orf160, LINC00044, U50HG, bA33E24.2, MGC16362, bA33E24.2, U50HG, NCRNA00044 |
| Region | GRCh38_6:85660950-85678736 Sequence |
| Ensembl | ENSG00000203875 |
| RefSeq | NR_003038 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR, Western blot, in vitro knockdown |
| Sample | BC tissues, Bladder cancer cell lines (SW780, UMUC3, 5637, T-24) |
| Expression Pattern | up-regulated |
| Function Description | SNGH5 was found upregulated in BC tissues and cell lines and a high level of SNGH5 was correlated with a poor prognosis. Silencing SNHG5 inhibited the proliferation ability of BC cells and such a function was attributed to its influence on cells cycle and apoptosis. |
| Pubmed ID | 29434891 |
| Year | 2017 |
| Title | lncRNA SNHG5 is associated with poor prognosis of bladder cancer and promotes bladder cancer cell proliferation through targeting p27. |
| External Links |
| Links for SNHG5 | GenBank HGNC lncrnadb Noncode |
| Links for bladder cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.